A detailed history of Worldquant Millennium Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Worldquant Millennium Advisors LLC holds 135,420 shares of GILD stock, worth $12.2 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
135,420
Previous 910,817 85.13%
Holding current value
$12.2 Million
Previous $62.5 Million 81.84%
% of portfolio
0.08%
Previous 0.57%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$66.59 - $83.99 $51.6 Million - $65.1 Million
-775,397 Reduced 85.13%
135,420 $11.4 Million
Q2 2024

Aug 14, 2024

BUY
$63.15 - $72.88 $52.9 Million - $61 Million
837,368 Added 1140.07%
910,817 $62.5 Million
Q4 2023

Feb 14, 2024

SELL
$73.27 - $83.09 $3.08 Million - $3.49 Million
-41,970 Reduced 36.36%
73,449 $5.95 Million
Q3 2023

Nov 14, 2023

BUY
$73.94 - $80.67 $1.16 Million - $1.26 Million
15,672 Added 15.71%
115,419 $8.65 Million
Q2 2023

Aug 14, 2023

SELL
$76.01 - $86.7 $20.6 Million - $23.5 Million
-271,429 Reduced 73.13%
99,747 $7.69 Million
Q1 2023

May 15, 2023

BUY
$77.31 - $88.08 $6.97 Million - $7.94 Million
90,182 Added 32.09%
371,176 $30.8 Million
Q4 2022

Feb 14, 2023

BUY
$62.32 - $89.47 $1.67 Million - $2.39 Million
26,768 Added 10.53%
280,994 $24.1 Million
Q3 2022

Nov 14, 2022

BUY
$59.54 - $68.01 $10.6 Million - $12.1 Million
177,815 Added 232.71%
254,226 $15.7 Million
Q2 2022

Aug 15, 2022

BUY
$57.72 - $65.01 $264,299 - $297,680
4,579 Added 6.37%
76,411 $4.72 Million
Q1 2022

May 16, 2022

SELL
$57.92 - $72.58 $672,798 - $843,089
-11,616 Reduced 13.92%
71,832 $4.27 Million
Q4 2021

Feb 14, 2022

SELL
$64.88 - $73.64 $145,331 - $164,953
-2,240 Reduced 2.61%
83,448 $6.06 Million
Q3 2021

Nov 15, 2021

SELL
$67.69 - $73.03 $312,727 - $337,398
-4,620 Reduced 5.12%
85,688 $5.99 Million
Q2 2021

Aug 16, 2021

SELL
$63.47 - $69.35 $1.17 Million - $1.28 Million
-18,389 Reduced 16.92%
90,308 $6.22 Million
Q3 2020

Nov 16, 2020

BUY
$62.1 - $78.08 $95,385 - $119,930
1,536 Added 1.43%
108,697 $6.87 Million
Q2 2020

Aug 14, 2020

SELL
$72.34 - $84.0 $2.01 Million - $2.33 Million
-27,773 Reduced 20.58%
107,161 $8.25 Million
Q1 2020

May 14, 2020

SELL
$62.63 - $80.22 $16.9 Million - $21.6 Million
-269,246 Reduced 66.62%
134,934 $10.1 Million
Q4 2019

Feb 14, 2020

SELL
$61.62 - $67.78 $1.67 Million - $1.84 Million
-27,158 Reduced 6.3%
404,180 $26.3 Million
Q3 2019

Nov 14, 2019

SELL
$62.51 - $69.0 $10.3 Million - $11.4 Million
-165,110 Reduced 27.68%
431,338 $27.3 Million
Q2 2019

Aug 14, 2019

BUY
$61.87 - $69.38 $6.04 Million - $6.77 Million
97,649 Added 19.58%
596,448 $40.3 Million
Q1 2019

May 14, 2019

BUY
$62.53 - $70.05 $31.2 Million - $34.9 Million
498,799 New
498,799 $32.4 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Worldquant Millennium Advisors LLC Portfolio

Follow Worldquant Millennium Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Worldquant Millennium Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worldquant Millennium Advisors LLC with notifications on news.